Clinafloxacin pharmacokinetics in subjects with various degrees of renal function

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2536-2542

  Randinitis, E J ^a   Koup, J R ^a   Rausch, G ^a   Abel, R ^a   Bron, N J ^a   Hounslow, N J ^a   Vassos, A B ^a   Sedman, A J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINAFLOXACIN;

ADULT; AGED; AGING; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE CLEARANCE; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; FLUOROQUINOLONES; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0034871757     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2536-2542.2001     Document Type: Article

References (21)

1. Effects of food and antacid on the pharmacokinetics of clinafloxacin
2. The tolerance and pharmacokinetics of clinafloxacin in healthy subjects
3. Central nervous system toxicity of quinolones: Human and animal findings
4. Prediction of creatinine clearance from serum creatinine
5. Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin
6. In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin
7. Bacterial eradication by clinafloxacin, CI-990, and ciprofloxacin employing MBC test, in-vitro time-kill and in-vivo time-kill studies
8. Structure-activity and structure-side-effect relationships for the quinolone antibacterials
9. In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers
10. Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates, including those with mutations in the gyrA, parC, and parE loci
11. Fluoroquinolone toxicities: An update
12. Antibiotic dosing in renal failure
13. Simplification of antibiotic dose adjustments in renal insufficiency: The DREM system
14. The emergence of bacterial resistance to antibiotics: Achieving optimum outcomes with clinafloxacin, seminar-in-print
15. Pharmacokinetics of clinafloxacin after single and multiple doses
16. Clinafloxacin pharmacokinetics in renal patients
17. Effect of age on clinafloxacin pharmacokinetics in healthy volunteers
18. Drug dosing in renal insufficiency
19. Pharmacokinetics of fleroxacin in renal impairment